NASDAQ:EXFY Expensify (EXFY) Stock Price, News & Analysis → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free EXFY Stock Alerts $1.64 +0.01 (+0.30%) (As of 12:40 PM ET) Add Compare Share Share Today's Range$1.60▼$1.6750-Day Range$1.43▼$2.4952-Week Range$1.40▼$8.25Volume107,220 shsAverage Volume631,045 shsMarket Capitalization$116.10 millionP/E RatioN/ADividend YieldN/APrice Target$5.93 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Expensify alerts: Email Address Expensify MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside263.7% Upside$5.93 Price TargetShort InterestHealthy4.96% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.57Based on 19 Articles This WeekInsider TradingAcquiring Shares$1.27 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.19) to ($0.06) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.19 out of 5 starsBusiness Services Sector117th out of 310 stocksPrepackaged Software Industry92nd out of 199 stocks 3.0 Analyst's Opinion Consensus RatingExpensify has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 4 hold ratings, and 2 sell ratings.Amount of Analyst CoverageExpensify has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.96% of the float of Expensify has been sold short.Short Interest Ratio / Days to CoverExpensify has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Expensify has recently increased by 28.82%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldExpensify does not currently pay a dividend.Dividend GrowthExpensify does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXFY. Previous Next 3.1 News and Social Media Coverage News SentimentExpensify has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.36 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 19 news articles for Expensify this week, compared to 4 articles on an average week.Search Interest2 people have searched for EXFY on MarketBeat in the last 30 days. MarketBeat FollowsOnly 3 people have added Expensify to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Expensify insiders have bought 10.48% more of their company's stock than they have sold. Specifically, they have bought $1,267,742.00 in company stock and sold $1,147,475.00 in company stock.Percentage Held by Insiders20.32% of the stock of Expensify is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions68.42% of the stock of Expensify is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Expensify are expected to grow in the coming year, from ($0.19) to ($0.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Expensify is -3.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Expensify is -3.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioExpensify has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIWhat is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. About Expensify Stock (NASDAQ:EXFY)Expensify, Inc. provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company's platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel. It also offers track and submit plans for individuals. The company was founded in 2008 and is based in Portland, Oregon.Read More EXFY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXFY Stock News HeadlinesApril 26, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) CEO David Michael Barrett Sells 15,910 SharesApril 23, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) CEO Sells $24,806.00 in StockApril 26, 2024 | Tranzact (Ad)What is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. April 20, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) Major Shareholder Steven J. Mclaughlin Buys 135,158 Shares of StockApril 18, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) CEO Sells $24,696.75 in StockApril 14, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) CEO David Michael Barrett Sells 16,740 SharesApril 9, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) CEO Sells $24,776.75 in StockApril 4, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) CEO David Michael Barrett Sells 13,300 SharesApril 26, 2024 | Tranzact (Ad)What is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. March 29, 2024 | insidertrades.comExpensify, Inc. (NASDAQ:EXFY) CEO Sells $22,207.57 in StockApril 25, 2024 | businesswire.comExpensify to Announce Q1 ResultsApril 24, 2024 | americanbankingnews.comExpensify (NASDAQ:EXFY) Price Target Lowered to $4.00 at CitigroupApril 23, 2024 | americanbankingnews.comExpensify, Inc. (NASDAQ:EXFY) CEO Sells $24,937.92 in StockApril 21, 2024 | investing.comExpensify executive buys shares worth over $216kApril 21, 2024 | americanbankingnews.comSteven J. Mclaughlin Acquires 135,158 Shares of Expensify, Inc. (NASDAQ:EXFY) StockApril 19, 2024 | markets.businessinsider.comJMP Securities Keeps Their Hold Rating on Expensify (EXFY)April 19, 2024 | investing.comExpensify executive buys shares worth over $466kApril 19, 2024 | americanbankingnews.comSteven J. Mclaughlin Buys 248,712 Shares of Expensify, Inc. (NASDAQ:EXFY) StockApril 2, 2024 | seekingalpha.comExpensify: A Company That Hopes To Turn The Corner In 2024March 20, 2024 | businesswire.comBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Expensify, Inc. (EXFY) InvestigationMarch 16, 2024 | finance.yahoo.comEXFY Apr 2024 2.500 callMarch 16, 2024 | investing.comExpensify CFO Ryan Schaffer sells shares worth $9,625March 16, 2024 | investing.comExpensify CEO sells shares worth over $15,000March 5, 2024 | seekingalpha.comExpensify: Poor Execution And Outlook (Rating Downgrade)March 1, 2024 | businesswire.comExpensify to Participate in Upcoming Investor EventFebruary 29, 2024 | seekingalpha.comExpensify May Have More Surprises In Store (Rating Upgrade)February 27, 2024 | finance.yahoo.comExpensify, Inc. (NASDAQ:EXFY) Q4 2023 Earnings Call TranscriptSee More Headlines Receive EXFY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Expensify and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today4/26/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:EXFY CUSIPN/A CIK1476840 Webwww.expensify.com Phone971-365-3939FaxN/AEmployees133Year FoundedN/APrice Target and Rating Average Stock Price Target$5.93 High Stock Price Target$12.00 Low Stock Price Target$2.00 Potential Upside/Downside+261.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,460,000.00 Net Margins-27.70% Pretax Margin-25.53% Return on Equity-41.91% Return on Assets-20.39% Debt Debt-to-Equity RatioN/A Current Ratio2.02 Quick Ratio2.02 Sales & Book Value Annual Sales$150.69 million Price / Sales0.77 Cash FlowN/A Price / Cash FlowN/A Book Value$1.46 per share Price / Book1.12Miscellaneous Outstanding Shares70,580,000Free Float56,238,000Market Cap$115.75 million OptionableOptionable Beta1.49 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. David Barrett (Age 47)Founder, CEO, President & Director Comp: $1.61MMr. Ryan Schaffer (Age 36)CFO & Director Comp: $873.09kMs. Anuradha Muralidharan (Age 40)COO & Director Comp: $460.59kMr. Jason Fahr Mills (Age 42)Chief Product Officer & Director Mr. Daniel Vidal (Age 35)Chief Strategy Officer & Director Cole EasonSecretaryMore ExecutivesKey CompetitorsXiao-INASDAQ:AIXICoreCardNYSE:CCRDDigiAsiaNASDAQ:FAASZenviaNASDAQ:ZENVRed CatNASDAQ:RCATView All CompetitorsInsiders & InstitutionsDavid Michael BarrettSold 15,910 sharesTotal: $24,819.60 ($1.56/share)David Michael BarrettSold 14,844 sharesTotal: $24,937.92 ($1.68/share)David Michael BarrettSold 15,800 sharesTotal: $24,806.00 ($1.57/share)Steven J MclaughlinBought 135,158 shares on 4/17/2024Total: $202,737.00 ($1.50/share)David Michael BarrettSold 16,575 sharesTotal: $24,696.75 ($1.49/share)View All Insider TransactionsView All Institutional Transactions EXFY Stock Analysis - Frequently Asked Questions Should I buy or sell Expensify stock right now? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Expensify in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXFY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXFY, but not buy additional shares or sell existing shares. View EXFY analyst ratings or view top-rated stocks. What is Expensify's stock price target for 2024? 8 Wall Street research analysts have issued 12 month target prices for Expensify's shares. Their EXFY share price targets range from $2.00 to $12.00. On average, they predict the company's share price to reach $5.93 in the next year. This suggests a possible upside of 263.7% from the stock's current price. View analysts price targets for EXFY or view top-rated stocks among Wall Street analysts. How have EXFY shares performed in 2024? Expensify's stock was trading at $2.47 on January 1st, 2024. Since then, EXFY stock has decreased by 34.0% and is now trading at $1.63. View the best growth stocks for 2024 here. Are investors shorting Expensify? Expensify saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,190,000 shares, an increase of 28.8% from the March 31st total of 1,700,000 shares. Based on an average daily trading volume, of 655,200 shares, the days-to-cover ratio is currently 3.3 days. Currently, 5.0% of the shares of the company are sold short. View Expensify's Short Interest. When is Expensify's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our EXFY earnings forecast. How were Expensify's earnings last quarter? Expensify, Inc. (NASDAQ:EXFY) announced its quarterly earnings results on Thursday, February, 22nd. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.06. The company earned $35.20 million during the quarter, compared to the consensus estimate of $36.85 million. Expensify had a negative net margin of 27.70% and a negative trailing twelve-month return on equity of 41.91%. The business's revenue was down 19.1% on a year-over-year basis. During the same period in the prior year, the company posted ($0.04) EPS. When did Expensify IPO? Expensify (EXFY) raised $234 million in an initial public offering on Wednesday, November 10th 2021. The company issued 9,730,776 shares at $23.00-$25.00 per share. How do I buy shares of Expensify? Shares of EXFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:EXFY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Expensify, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
